<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1550">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04418544</url>
  </required_header>
  <id_info>
    <org_study_id>002 Soniphi</org_study_id>
    <nct_id>NCT04418544</nct_id>
  </id_info>
  <brief_title>Vocal Feature Analysis Algorithm for COVID-19 Detection</brief_title>
  <official_title>Testing of Soniphi Vocal Feature Analysis Algorithm for COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Soniphi LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>UserWise</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Soniphi LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational, prospective, non-randomized, non-significant risk study collecting&#xD;
      voice recordings from subjects who are being tested for COVID-19 by laboratory analysis of&#xD;
      specimens obtained by nasal or naso-pharyngeal (NP) swab. Patients record their voices&#xD;
      through an app on their mobile phone. Patients and health care providers will be blinded to&#xD;
      the swab test results during Phase 2 of the study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this observational study is to determine if the Vocal Feature&#xD;
      Analysis (VFA) Algorithm developed by Soniphi can screen for the COVID-19 condition from&#xD;
      voice recordings. Patients eligible for the study are those being tested for COVID-19 based&#xD;
      on molecular diagnostic testing of specimens obtained by nasal or nasopharyngeal swab.&#xD;
&#xD;
      No clinical decisions will be based on the recordings. The results of the algorithm analysis&#xD;
      will not be made available to the subjects or their healthcare providers during or after the&#xD;
      study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and Specificity</measure>
    <time_frame>6 months</time_frame>
    <description>compare Sensitivity and Specificity to standard swab test</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Do not test positive for COVID</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COVID-19 Positive</arm_group_label>
    <description>Test positive for Covid using swab test.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Device used to record voice for screening</intervention_name>
    <description>voice recording</description>
    <arm_group_label>COVID-19 Positive</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients being tested for COVID-19.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female, aged &gt; 18 years&#xD;
&#xD;
          2. Provide a valid electronic informed consent form&#xD;
&#xD;
          3. Eligible patients are those meeting SOC guidelines for swab tests for COVID-19 and&#xD;
             those providing an evaluable sample.&#xD;
&#xD;
          4. Stated willingness to provide evidence of their lab test results&#xD;
&#xD;
          5. Pregnant or lactating women may participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Presence of tracheostomy or past tracheostomy with permanent change to the voice due&#xD;
             complications that involved the vocal cords.&#xD;
&#xD;
          2. Prior surgery which may influence the vocal cords, e.g., laryngeal, tracheal or&#xD;
             esophageal surgery&#xD;
&#xD;
          3. Prior head, neck or throat cancer treated with radical neck dissection and/or&#xD;
             radiation therapy that may influence the vocal cords&#xD;
&#xD;
          4. Treatment with another investigational drug or device within 30 days prior to signing&#xD;
             Consent Form&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen Steady, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soniphi LLC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stephen Steady, MD</last_name>
    <phone>(415) 309-3242</phone>
    <email>slsteady@vivacitashealthcare.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ari Levitt, MD</last_name>
    <phone>(206) 731-9172</phone>
    <email>aril@sonaphi.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Soniphi</name>
      <address>
        <city>Sebastopol</city>
        <state>California</state>
        <zip>95472</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M Sanderson, BS</last_name>
      <email>research@soniphi.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>June 1, 2020</study_first_submitted>
  <study_first_submitted_qc>June 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 5, 2020</study_first_posted>
  <last_update_submitted>October 28, 2020</last_update_submitted>
  <last_update_submitted_qc>October 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

